Latest News by Industry
Karyopharm Therapeutics Inc. [KPTI] has reported fiscal Q1 loss of $34.10 million.
On a per-share basis, the DE based company said its diluted earnings are $0.30.
The Pharmaceutical Preparations firm posted revenue of $38.70 million in this period.
Also Read: